Oncolytic replication-competent adenovirus suppresses tumor angiogenesis through preserved E1A region

This publication has 38 references indexed in Scilit:

• Pancreatic Cancer Registry in Japan
  Pancreas, 2004
• Gene therapy for intraperitoneally disseminated pancreatic cancers by Escherichia coli uracil phosphoribosiltransferase (UPRT) gene mediated by restricted replication‐competent adenoviral vectors
  International Journal of Cancer, 2002
• Gene transfer of antisense hypoxia inducible factor-1 α enhances the therapeutic efficacy of cancer immunotherapy
  Gene Therapy, 2001
• Gene therapy for pancreatic cancer—current and prospective strategies
  Surgical Oncology, 2000
• Mechanism of regulation of the hypoxia-inducible factor-1alpha by the von Hippel-Lindau tumor suppressor protein
  The EMBO Journal, 2000
• Effective Gene Therapy for Pancreatic Cancer by Cytokines Mediated by Restricted Replication-Competent Adenovirus
  Human Gene Therapy, 2000
• Hypoxia-inducible Factor 1α (HIF-1α) Protein Is Rapidly Degraded by the Ubiquitin-Proteasome System under Normoxic Conditions
  Journal of Biological Chemistry, 1997
• An Adenovirus Mutant That Replicates Selectively in p53- Deficient Human Tumor Cells
  Science, 1996
• Survival after resection for ductal adenocarcinoma of the pancreas
  British Journal of Surgery, 1996
• Establishment of six human pancreatic cancer cell lines and their sensitivities to anti-tumor drugs.
  The Tohoku Journal of Experimental Medicine, 1986